Work

Fibroblast Metabolic Reprogramming in Crohn's Disease: Recent Insights Into Pentose Phosphate Pathway Signalling in Intestinal Fibrosis

Year: 2026
Type: article
Abstract: ABSTRACT Intestinal fibrosis is a major complication of Crohn's disease (CD), for which no effective antifibrotic therapies are currently available, partly due to an incomplete understanding of its underlying mechanisms. Emerging evidence suggests that metabolic reprogramming of stromal cells may contribute to fibrogenesis. This Y‐ECCO literature review summarises the study by Zhou et al., which investigated metabolic alterations in intestinal fibrosis using multi‐omics approaches. Paired stricturing and non‐stricturing intestinal specimens from patients with CD were analysed using metabolomics, single‐cell transcriptomics, and spatial transcriptomics, complemented by functional validation in primary human intestinal myofibroblasts and murine models. The study identified activation of the pentose phosphate pathway (PPP) in fibrotic intestinal tissue, predominantly driven by fibroblasts. Xylulose‐5‐phosphate (Xu5P), a key PPP metabolite, was enriched in stricturing disease, correlated with fibrosis severity, and promoted fibroblast activation in vitro and in vivo. Mechanistically, Xu5P production was regulated by xylulokinase (XYLB) and negatively controlled by circular RNA circPLCE1, which was downregulated in fibrotic tissue. Loss of circPLCE1 enhanced PPP activity and fibrotic remodelling, defining a circPLCE1–XYLB–Xu5P axis. These findings identify metabolic reprogramming as a key driver of intestinal fibrosis in CD and suggest potential diagnostic and therapeutic targets, although clinical translation of PPP‐targeting strategies remains to be established.
Source: JCC Plus
Language: English
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7168082078
FWCI:
Cites: 11
Cited by:
Related to: 10